Dynamic List Information
Dynamic List Data
Study Title
EF-36/Keynote B36: A Pilot, Single Arm, Open-Label Study of Tumor Treating Fields(TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Intrathoracic Non-small Cell Lung Cancer
Sponsor Name
NovoCure GmbH
NCT Number
NCT04892472
IDE Number
G210071
CMS Approval Date
2021-07-21
Clinical Trial Link
Category
B